Alzheimer’s disease is commonly thought of as an older person’s illness. But new research from Columbia University and the ...

In the U.S., key risk factors for Alzheimer's disease were tied to cognitive function as early as ages 24 to 44. (Lancet ...

A vaccine designed to help protect you from an extremely painful viral infection has another important benefit. A new study ...

Dementia affects more than 6 million Americans and accounts for more than 100,000 deaths each year, with a startling NYU ...

A randomized, placebo-controlled clinical trial is underway called Valacyclovir Treatment of Alzheimer’s Disease but results ...

A team of researchers from the Institute for Basic Science (IBS) in South Korea has made an important discovery that could ...

The Trump administration is freezing, delaying and revoking funding for dementia research, setting back discoveries of ...

The Alzheimer’s Association invites the community to register for 2025 Walks to End Alzheimer’s, taking place across the region, this fall. “Now is the moment we’ve been waiting for,” said Annemarie ...

What’s exciting is that medications that block CXCR3 are already being tested for other health problems, like arthritis. If ...

Memory loss is a potential sign of dementia that occurs in progressive stages. Learn about treating and preventing dementia ...

A new study confirms that plasma p-tau181 levels can identify subjective cognitive decline (SCD) as a distinct early stage of ...